# Terumo BCT Ltd – FDA Inspection, Jun 26, 2026

Source: https://www.keypedia.com/records/fda_inspections/terumo-bct-ltd/d3d69354-9681-4ae4-9a29-2fe8f3cde9fd
Source feed: FDA_Inspections

> FDA inspection 1323646 of Terumo BCT Ltd, June 26, 2026. 2 citations under 21 CFR part 211. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1323646
- Company Name: Terumo BCT Ltd
- Inspection Date: 2026-06-26
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Office of Inspections and Investigations
- Citation Count: 2

## Related Documents

- [FDA Inspection 1195522 - 2023-01-19](https://www.keypedia.com/records/fda_inspections/terumo-bct-ltd/f6840fec-29cd-49bb-a76e-2324d462ff6e)
- FDA Inspection 1207405 - 2022-02-11
- FDA Inspection 1115666 - 2019-04-11
- FDA Inspection 973196 - 2016-04-28
- [FDA Inspection 873451 - 2014-03-28](https://www.keypedia.com/records/fda_inspections/terumo-bct-ltd/666cfb00-f368-45d6-995f-5fa4f57e0343)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/emily-b-camire/dff5f4c6-bcbe-4ef1-ac0b-1b2701b311ef)

Company: https://www.keypedia.com/companies/terumo-bct-ltd/182a5d92-4c5c-4393-95cd-45250ca7eb25

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8
